Cell-free DNA and circulating TERT promoter mutation for disease monitoring in newly-diagnosed glioblastoma

RT @NeuropathClinic: Cell-free DNA and circulating TERT promoter mutation for disease monitoring in newly-diagnosed glioblastoma. #neuropat…

Cell-free DNA and circulating TERT promoter mutation for disease monitoring in newly-diagnosed glioblastoma. #neuropath https://t.co/iRVqD8F60T

Cell-free DNA and circulating TERT promoter mutation for disease monitoring in newly-diagnosed glioblastoma. https://t.co/DIDHfzW2WB https://t.co/e7NlIftE3B